Yüklüyor......
Ketamine: Leading us into the future for development of antidepressants
Numerous randomized double-blind clinical trials have consistently shown that that a single intravenous administration of a subanesthetic dose of ketamine to treatment-resistant depressed patients significantly improved depressive symptomatology rapidly, within two hours, with the effect lasting up...
Kaydedildi:
| Yayımlandı: | Behav Brain Res |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7890296/ https://ncbi.nlm.nih.gov/pubmed/32023492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbr.2020.112532 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|